Author
Share this page:
Tag Archives: hepatitis
Are Patients Receiving the Latest Anti-HCV Drugs?
Less than 20% of patients infected with the most common Hepatitis C virus (HCV) genotype receive the latest drugs approved by the US Food and Drug Administration (FDA), according to the August issue of Clinical Gastroenterology and Hepatology. This low … Continue reading
Posted in Liver/Biliary, Technology
Tagged Cirrhosis, clinical tirial, DAA, direct-acting anti-viral agent, drug, Fibrosis, HCV, hepatitis, liver, patient management, therapy, treatment, virus
2 Comments
What are the Effects of Albumin in Patients With SBP?
Albumin infusion prevents renal impairment and reduces mortality among patients with spontaneous bacterial peritonitis (SBP), according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology. SBP is a common bacterial infection among cirrhotic patients and a … Continue reading
Posted in Liver/Biliary
Tagged ascites, bacterial infection, blood volume, Cirrhosis, complication, hepatitis, immune response, Inflammation, kidney, liver disease, nephrology, therapy, treatment
2 Comments
Differences in HCV Infection, and Effects of Treatment, Among Countries
Hepatitis C virus (HCV) infections have developed and spread at different rates in different countries, affecting outcomes of therapy, according to the October issue of Gastroenterology. Specific details of each population must therefore be considered in designing prevention and treatment … Continue reading
Posted in Liver/Biliary
Tagged Cirrhosis, disease progression, Epidemiology, Europe, Fibrosis, hepatitis, Liver Cancer, liver disease, transplant, United States
Leave a comment
A Special Issue on Viral Hepatitis
The May issue of Gastroenterology features a very special supplement—“Viral Hepatitis: A Changing Field”—comprising 17 review and commentary articles from international leaders in hepatitis treatment and research. The issue provides insight into the rapid progress made in the treatment and … Continue reading
Posted in Cancer, Liver/Biliary, Technology
Tagged Cirrhosis, editorial, HAV, HBV, HCV, hepatitis, HEV, perspective, review, therapy, treatment, Virology
2 Comments
Why are Some Immunized Children Still At Risk for HBV Infection?
Despite immunization, children born to mothers with replicating HBV (marked by hepatitis B e antigen, or HBeAg) are still at risk for infection, according to the April issue of Gastroenterology. Mother-to-infant transmission is the major cause of hepatitis B virus … Continue reading
Posted in Liver/Biliary
Tagged baby, Cirrhosis, HCC, hepatitis, mother to child transmission, mother-child, pediatric, Prevention, vaccination, vaccine
Leave a comment
What Factors Predict Recovery From Chronic HBV Infection?
A low and rapidly decreasing level of Hepatitis B surface antigen (HBsAg) is a good sign for patients with chronic HBV infection, according to the March issue of Clinical Gastroenterology and Hepatology. Tracking progression of chronic HBV infection can be … Continue reading
Posted in Liver/Biliary
Tagged Cirrhosis, cure, Fibrosis, HCC, hepatitis, liver disease, prognosis, recovery, treatment, virus
Leave a comment
How Does Deferasirox Reduce Liver Fibrosis?
Liver fibrosis is reduced in patients with iron overload β-thalassemia and hepatitis C given the iron chelator deferasirox, according to Yves Deugnier et al. in the October issue of Gastroenterology. The liver is the main site of iron accumulation in … Continue reading
Posted in Liver/Biliary, Technology
Tagged ALT, Cirrhosis, Clinical Trial, HCV, hepatitis, iron, Ishak stage, liver diseaes, outcome, therapy
Leave a comment
Kristine Novak, PhD, Science Editor
